Global Contrast-Enhanced Ultrasound Market Set to Reach $2.1 Billion by 2028, Driven by Rising Geriatric Population and Research Activities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software], Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology), End User (Hospital, Clinics, ASCs) & Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.


The global contrast-enhanced ultrasound market is projected to experience substantial growth, reaching USD 2.1 billion by 2028, up from USD 1.6 billion in 2023, with a CAGR of 6.1% from 2023 to 2028.

Key factors driving this growth include the rising geriatric population and increased usage of contrast agents. Additionally, growing research and development activities, government initiatives, and a rising number of clinical trials are contributing to the expansion of the contrast-enhanced ultrasound market.

Segment Insights

The market is segmented into equipment, contrast agents, and software and services. In 2022, the contrast-enhanced ultrasound equipment segment held the largest market share, primarily due to the introduction of technologically advanced systems and the increasing adoption of contrast-enhanced ultrasound systems by end users.

Therapeutic Applications on the Rise

In terms of application, the therapeutic application segment is projected to register the highest CAGR during the forecast period (2023-2028). This is attributed to the growing use of contrast agents for targeted drug delivery and patient monitoring.

Asia Pacific Emerges as a High-Growth Region

The Asia Pacific region is expected to witness the highest growth in the contrast-enhanced ultrasound market during the forecast period. Factors driving this growth include evolving healthcare infrastructure and increased focus from major market players. Emerging economies like China and India are experiencing rapid growth in healthcare infrastructure, leading to significant investments in advanced imaging systems by hospitals and diagnostic centers.

Market Dynamics

Drivers:

Increasing incidence of chronic diseases

Technological advancements in contrast-enhanced ultrasound systems

Initiatives for commercialization of diagnostic imaging equipment

Restraints:

Risks associated with contrast agents

Opportunities:

Growth opportunities in emerging economies

Establishment of hospitals and diagnostic imaging centers

Challenges:

Shortage of skilled sonographers

Presence of alternative techniques

Key Market Players

Prominent companies in the contrast-enhanced ultrasound market include Bayer AG, Bracco Imaging S.p.A., Canon Inc., Esaote S.p.A., GE Healthcare, Guerbet, JB Pharma, Koninklijke Philips N.V., Lantheus, Leriva, NanoPET Pharma GmbH, Revvity, Samsung Electronics Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers, and Solstice Pharmaceuticals B.V., among others.

Premium Insights

The report provides valuable premium insights into the market, covering aspects such as the rising prevalence of chronic diseases, the contrast agents segment’s expected highest CAGR, the dominance of therapeutic applications, and the significance of hospitals and surgical centers. Additionally, it highlights China’s expected highest growth rate in the contrast-enhanced ultrasound market.

Key Attributes:

Report Attribute
Details

No. of Pages
172

Forecast Period
2023 – 2028

Estimated Market Value (USD) in 2023
$1.6 Billion

Forecasted Market Value (USD) by 2028
$2.1 Billion

Compound Annual Growth Rate
6.1%

Regions Covered
Global

For more information about this report visit https://www.researchandmarkets.com/r/f44xk5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.